2023
DOI: 10.1002/ccr3.6996
|View full text |Cite
|
Sign up to set email alerts
|

Erdheim‐Chester disease: A multisystem disease case illustration with rare manifestations and treatment challenges

Abstract: Erdheim-Chester disease is a rare multisystemic disease. A 50-year-old woman, presented with a recurrent pain and swelling of the left knee. Bone scintigraphy showed increased tracer uptake of peripheral skeleton. The computed tomography showed tissular infiltration in the retroperitoneum, around the vessels.Immunohistochemistry showed CD68 (+) and CD1a (−).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…If interferon-α fails, imatinib mesylate has been suggested as a potential experimental alternative therapy by some reports [ 15 ]. Furthermore, treatment with a BRAF inhibitor has been considered to be a helpful therapy, as individuals with multisystemic and refractory ECD and BRAF V600E gene mutations have shown partial clinical responses following treatment with a BRAF inhibitor [ 9 , 16 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…If interferon-α fails, imatinib mesylate has been suggested as a potential experimental alternative therapy by some reports [ 15 ]. Furthermore, treatment with a BRAF inhibitor has been considered to be a helpful therapy, as individuals with multisystemic and refractory ECD and BRAF V600E gene mutations have shown partial clinical responses following treatment with a BRAF inhibitor [ 9 , 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…For knee pain and contracture, radiologic evaluation (simple radiography and magnetic resonance imaging (MRI)) of the knee joint was performed at another hospital, and the findings showed osteosclerotic lesions, which were thought to be bone metastases; therefore, the patient was referred to the hemato-oncology department of our hospital for cancer evaluation (Figure 1). treatment regimens, including some conventional medicines and, more recently, targeted therapies, have been tried [9].…”
Section: Case Presentationmentioning
confidence: 99%
See 1 more Smart Citation